Eser, O. Et Al. 2018. Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.. Ocular immunology and inflammation , vol.26 , 1005-1014.

Eser, O., Oray, M., & TUGAL-TUTKUN, I., (2018). Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.. Ocular immunology and inflammation , vol.26, 1005-1014.

Eser, Ozturk, Merih ORAY, And I TUGAL-TUTKUN. "Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.," Ocular immunology and inflammation , vol.26, 1005-1014, 2018

Eser, Ozturk Et Al. "Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.." Ocular immunology and inflammation , vol.26, pp.1005-1014, 2018

Eser, O. Oray, M. And TUGAL-TUTKUN, I. (2018) . "Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.." Ocular immunology and inflammation , vol.26, pp.1005-1014.

@article{article, author={Ozturk Eser Et Al. }, title={Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.}, journal={Ocular immunology and inflammation}, year=2018, pages={1005-1014} }